Joe Suttner

Joe brings over 20 years of drug development experience in both the biotech and pharma industries. Joe most recently served as Vice President, Clinical Operations at Attralus working in the cardiac amyloidosis space.

Prior to joining Attralus he worked at PellePharm, a subsidiary of BridgeBio. He and his teamed worked within the rare disease space, specifically programs targeting Gorlin disease and high frequency basal cell carcinoma. Before joining PellePharm, Joe was part of Dermira’s management team involved in project management, alliance management and NDA/sBLA submission activities. He also participated on acquisition and partnership teams for the company’s first biologic program for Atopic Dermatitis. Previously, Joe provided leadership to Allergen Research Corporation (ARC), now Aimmune, as Vice President of Clinical Operations. At Aimmune, Joe helped establish a network of food allergy centers in collaboration with patient advocacy groups resulting in greater study access for patients worldwide. His experience within the industry has included roles at Amgen, Allergan, Ipsen, and Peplin. Joe earned his BA at California State University Long Beach and his MBA at the University of Liverpool.

Joe splits his time between the California desert and New Orleans. He belongs to two charitable Krewes and rides in their Mardi Gras parades each Carnivale season as well as the city’s annual Easter parade. He shares his home with a chunky English Bulldog named Beaux.